UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Utilization and outcomes of low dose versus high dose cisplatin in head and neck cancer patients receiving concurrent radiation

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.6019-6019

2015

Link zum Volltext

Verfügbarkeit prüfen

Growing Healing Touch as supportive cancer care in western New York

Journal of clinical oncology, 2017-02, Vol.35 (5_suppl), p.176-176

2017

Link zum Volltext

Verfügbarkeit prüfen

Symptom burden and functioning status in patients with advanced upper gastrointestinal cancers

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.311-311

2023

Link zum Volltext

Verfügbarkeit prüfen

Racial disparities in comprehensive biomarker testing and clinical trial enrollment among patients with metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.125-125

2021

Link zum Volltext

Verfügbarkeit prüfen

Racial distribution of clinical trial participants in the United States

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18516-e18516

2021

Link zum Volltext

Verfügbarkeit prüfen

Racial disparities in biomarker testing and clinical trial enrollment in non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9005-9005

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of gastric cancer treatment pathways on patient outcomes in a community oncology practice setting

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.299-299

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of bolus versus continuous infusion of doxorubicin (DOX) on cardiotoxicity in patients with breast cancer (BC) and sarcomas: Analysis of real-world data

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19123-e19123

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes between patients with and without RET fusions in advanced/metastatic non-small cell lung cancer in the United States

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21693-e21693

2020

Link zum Volltext

Verfügbarkeit prüfen

Biomarker testing patterns in patients with stage IV non-small cell lung cancer (NSCLC) in U.S. community-based oncology practice setting

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.300-300

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported symptom burden and functioning in patients with advanced esophageal, gastroesophageal junction (GEJ), and gastric cancer undergoing chemotherapy

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.183-183

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes and patient (pt) characteristics for the second-line (2L) treatment of gastric, esophageal, or gastroesophageal junction (GEJ) adenocarcinoma (EGAC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16011-e16011

2018

Link zum Volltext

Verfügbarkeit prüfen

Olaratumab for the treatment of patients (pts) with advanced/metastatic soft tissue sarcoma (STS): Treatment patterns in the United States (US) during the first year post-approval

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e23535-e23535

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment sequences in non-small cell lung cancer in the United States from 2014-2016

Journal of clinical oncology, 2017-03, Vol.35 (8_suppl), p.237-237

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment and outcomes for patients (pts) with selected advanced/metastatic cancers by place of care

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20717-e20717

2019

Link zum Volltext

Verfügbarkeit prüfen

Geographic and site variability in the treatment of patients with metastatic gastric cancer

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.153-153

2017

Link zum Volltext

Verfügbarkeit prüfen

Patterns of chemotherapy (CT) use in a U.S.-wide cohort of patients (pts) with metastatic gastric cancer (MGC)

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.112-112

2018

Link zum Volltext

Verfügbarkeit prüfen

Understanding the patient experience with soft tissue sarcoma: A systematic review of the literature

Journal of clinical oncology, 2016-03, Vol.34 (7_suppl), p.61-61

2016

Link zum Volltext

Verfügbarkeit prüfen

Oncologist preferences in advanced soft tissue sarcoma: A discrete choice experiment

Journal of clinical oncology, 2017-03, Vol.35 (8_suppl), p.147-147

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of second-line treatment for non-small cell lung cancer (NSCLC) among patients ≥ 70 versus < 70 years of age

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e19018-e19018

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognosis and treatment of patients with peripheral T-cell lymphoma: The M. D. Anderson Cancer Center experience

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8051-8051

2010

Link zum Volltext

Verfügbarkeit prüfen

Physician decisions related to maintenance therapy for advanced non-small cell lung cancer (NSCLC) in the United States (US)

Journal of clinical oncology, 2016-03, Vol.34 (7_suppl), p.182-182

2016

Link zum Volltext

Verfügbarkeit prüfen

Cost-minimization analysis of pemetrexed/carboplatin with maintenance pemetrexed (PemC) versus paclitaxel/carboplatin/bevacizumab with maintenance bevacizumab (PCB) in nonsquamous non-small cell lung cancer (NS-NSCLC)

Journal of clinical oncology, 2013-11, Vol.31 (31_suppl), p.263-263

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of soluble MUC1 and anti-MUC1 antibody levels in patients with diffuse large B-cell lymphoma

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6586-6586

2004

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of soluble MUC1 and anti-MUC1 antibody levels in patients with diffuse large B-cell lymphoma

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6586-6586

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 101

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(101)

Sprache

Englisch
(101)
Japanisch
(4)

Erscheinungsjahr

n.n

Kollektion

Free E-Journal (出版社公開部分のみ）
(101)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(101)
NUS Single-Journal Subscriptions
(101)
IngentaConnect Journals
(24)
IngentaConnect
(24)
MEDLINE
(7)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Utilization and outcomes of low dose versus high dose cisplatin in head and neck cancer patients receiving concurrent radiation

Growing Healing Touch as supportive cancer care in western New York

Symptom burden and functioning status in patients with advanced upper gastrointestinal cancers

Racial disparities in comprehensive biomarker testing and clinical trial enrollment among patients with metastatic colorectal cancer (mCRC)

Racial distribution of clinical trial participants in the United States

Racial disparities in biomarker testing and clinical trial enrollment in non-small cell lung cancer (NSCLC)

Impact of gastric cancer treatment pathways on patient outcomes in a community oncology practice setting

Impact of bolus versus continuous infusion of doxorubicin (DOX) on cardiotoxicity in patients with breast cancer (BC) and sarcomas: Analysis of real-world data

Clinical outcomes between patients with and without RET fusions in advanced/metastatic non-small cell lung cancer in the United States

Biomarker testing patterns in patients with stage IV non-small cell lung cancer (NSCLC) in U.S. community-based oncology practice setting

Patient-reported symptom burden and functioning in patients with advanced esophageal, gastroesophageal junction (GEJ), and gastric cancer undergoing chemotherapy

Real-world outcomes and patient (pt) characteristics for the second-line (2L) treatment of gastric, esophageal, or gastroesophageal junction (GEJ) adenocarcinoma (EGAC)

Olaratumab for the treatment of patients (pts) with advanced/metastatic soft tissue sarcoma (STS): Treatment patterns in the United States (US) during the first year post-approval

Treatment sequences in non-small cell lung cancer in the United States from 2014-2016

Treatment and outcomes for patients (pts) with selected advanced/metastatic cancers by place of care

Geographic and site variability in the treatment of patients with metastatic gastric cancer

Patterns of chemotherapy (CT) use in a U.S.-wide cohort of patients (pts) with metastatic gastric cancer (MGC)

Understanding the patient experience with soft tissue sarcoma: A systematic review of the literature

Oncologist preferences in advanced soft tissue sarcoma: A discrete choice experiment

Comparative effectiveness of second-line treatment for non-small cell lung cancer (NSCLC) among patients ≥ 70 versus < 70 years of age

Prognosis and treatment of patients with peripheral T-cell lymphoma: The M. D. Anderson Cancer Center experience

Physician decisions related to maintenance therapy for advanced non-small cell lung cancer (NSCLC) in the United States (US)

Cost-minimization analysis of pemetrexed/carboplatin with maintenance pemetrexed (PemC) versus paclitaxel/carboplatin/bevacizumab with maintenance bevacizumab (PCB) in nonsquamous non-small cell lung cancer (NS-NSCLC)

Prognostic value of soluble MUC1 and anti-MUC1 antibody levels in patients with diffuse large B-cell lymphoma

Prognostic value of soluble MUC1 and anti-MUC1 antibody levels in patients with diffuse large B-cell lymphoma

Aktive Filter

Suchergebnisse filtern